Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market

Philip J. Almeter, Eugene A. Hessel, Jonathan A. Labuhn, Peter E. Morris

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{ca19be29e1254843b07138f366645526,

title = "Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market",

author = "Almeter, {Philip J.} and Hessel, {Eugene A.} and Labuhn, {Jonathan A.} and Morris, {Peter E.}",

year = "2019",

month = apr,

doi = "10.1213/ANE.0000000000004042",

language = "English",

volume = "128",

pages = "E55--E56",

number = "4",

}

TY - JOUR

T1 - Editorial by US Food and Drug Administration Attorney Fails to Address Core and Ongoing Issues Seen With Vasopressin Market

AU - Almeter, Philip J.

AU - Hessel, Eugene A.

AU - Labuhn, Jonathan A.

AU - Morris, Peter E.

PY - 2019/4

Y1 - 2019/4

UR - http://www.scopus.com/inward/record.url?scp=85063260679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063260679&partnerID=8YFLogxK

U2 - 10.1213/ANE.0000000000004042

DO - 10.1213/ANE.0000000000004042

M3 - Letter

C2 - 30730466

AN - SCOPUS:85063260679

SN - 0003-2999

VL - 128

SP - E55-E56

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

IS - 4

ER -